These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15648247)

  • 1. The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Lambregts D; Irngartinger M; Frijlink HW
    Pharm Res; 2004 Dec; 21(12):2167-74. PubMed ID: 15648247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Lambregts D; Irngartinger M; Frijlink HW
    Pharm Res; 2004 Dec; 21(12):2158-66. PubMed ID: 15648246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):197-205. PubMed ID: 15567318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Kussendrager KD; Frijlink HW
    Int J Pharm; 2003 Jul; 260(2):201-16. PubMed ID: 12842340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Eur J Pharm Biopharm; 2003 Sep; 56(2):291-302. PubMed ID: 12957644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2003 Jul; 260(2):187-200. PubMed ID: 12842339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation.
    Dickhoff BH; Ellison MJ; de Boer AH; Frijlink HW
    Eur J Pharm Biopharm; 2002 Sep; 54(2):245-8. PubMed ID: 12191698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixing time effects on the dispersion performance of adhesive mixtures for inhalation.
    Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer HA
    PLoS One; 2013; 8(7):e69263. PubMed ID: 23844256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation.
    de Boer AH; Dickhoff BH; Hagedoorn P; Gjaltema D; Goede J; Lambregts D; Frijlink HW
    Int J Pharm; 2005 Apr; 294(1-2):173-84. PubMed ID: 15814242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle.
    de Boer AH; Le Brun PP; van der Woude HG; Hagedoorn P; Heijerman HG; Frijlink HW
    Eur J Pharm Biopharm; 2002 Jul; 54(1):17-24. PubMed ID: 12084498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
    de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW
    Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic time scales in adhesive mixing investigated by dry particle sizing.
    Nguyen D; Rasmuson A; Niklasson Björn I; Thalberg K
    Eur J Pharm Sci; 2015 Mar; 69():19-25. PubMed ID: 25576090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates.
    Zeng XM; Martin GP; Marriott C; Pritchard J
    J Pharm Pharmacol; 2000 Oct; 52(10):1211-21. PubMed ID: 11092565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
    Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.